Pediatric Hospital Medicine

CME/CE credit: Up to 50 AMA PRA Category 1 Credits*
Length of Time for Completion: 50+ hours
Number of questions to complete: All available questions

Planning Committee, Writers, and Reviewers:

Adam Rosh, MD: Planner, Reviewer 
Emergency Medicine Physician 
Chief Medical Officer, Blueprint Test Prep/Rosh Review 

Amy Rontal, MD: Planner, Reviewer 
Director of Medical Content, Blueprint Test Prep/Rosh Review 
Assistant Professor of Emergency Medicine 
Beaumont Health Systems/Oakland University

Jessica Leigh Komlos, MD: Planner, Writer, Reviewer 
Content Champion – Pediatrics, Blueprint Test Prep/Rosh Review
St. Luke’s University Health Network, Bethlehem, PA

Target Audience: Pediatric physicians
Learning Objectives: Upon completion of this educational activity, participants will be able to:

  • Comprehensively review the core content of pediatric hospital medicine.
  • Identify the fundamental concepts and key topics needed to successfully complete the pediatric hospital medicine examination.
  • Effectively translate the acquired academic knowledge into improved diagnostics and subsequently implement a better treatment plan for their patients.

Accreditation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Wayne State University School of Medicine and Rosh Review. The Wayne State University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit:
The Wayne State University School of Medicine designates this enduring material for a maximum of 100 AMA PRA Category 1 Credits. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information
Disclosures:  Wayne State University School of Medicine requires that everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with ineligible companies. “Ineligible companies” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

No commercial relationships with ineligible companies:

Adam Rosh, MD
Amy Rontal, MD
Jessica Leigh Komlos, MD

Investigational and/or Off-Label Use of Commercial Products and Devices:
There is no mention of investigational and/or off-label use of commercial products.

Acknowledgment of Commercial Support: There is no commercial support received for this educational activity.

Technical Requirements: Internet connection

For CME-related questions about this activity, contact Taylor Lauzon at cme@roshreview.com